Effect of physical activity on the severity of irritable bowel syndrome (IBS) symptoms
DOI:
https://doi.org/10.12775/QS.2024.16.52921Keywords
IBS, IBS management, IBS treatment, irritable bowel syndrome, physical activityAbstract
Irritable bowel syndrome is a chronic gastrointestinal disease whose symptoms affect patients' daily lives. Exacerbation of symptoms can worsen patients' quality of life and lead to depressive-anxiety and somatoform disorders. The associated costs burden not only the patients, but also those around them. The etiology of IBS is multifactorial and not fully understood. The brain-gut axis remains a subject of research, which may involve the development of new, effective therapies for the treatment of IBS in the future. Pharmacological and non-pharmacological methods are used to treat IBS. In order to provide the patient with the best possible treatment results in the absence of significant side effects, research is being conducted on the possibilities of non-pharmacological patient management. Currently, there are numerous studies on the effect of physical activity on the severity of symptoms in IBS patients. The results show that the introduction of moderate-intensity physical activity has positive effects in terms of alleviating gastrointestinal symptoms, reducing the severity of psychological and somatoform symptoms, and improving patients' well-being as well as quality of life. Appropriate physical activity is acceptable to patients and rated by them as positive and having a beneficial effect on IBS symptoms. The lack of patient-reported significant side effects is important. Given the results of the study, it seems beneficial to recommend that IBS patients perform moderate physical activity to alleviate and control symptoms. It is necessary to educate patients and individualize physical activity recommendations to match the type of activity to patients' abilities and needs.
References
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 Apr;130(5):1480-91. doi: 10.1053/j.gastro.2005.11.061. Erratum in: Gastroenterology. 2006 Aug;131(2):688.
https://theromefoundation.org/rome-iv/rome-iv-criteria/ Access date: 15.05.2024.
Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X. Epub 2020 Jul 20. Erratum in: Lancet Gastroenterol Hepatol. 2020 Dec;5(12):e8.
Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000 Sep;119(3):654-60. doi: 10.1053/gast.2000.16484.
Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Jul;50(2):132-143. doi: 10.1111/apt.15325.
Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, et al. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Aliment Pharmacol Ther. 2015 Mar;41(5):449-58. doi: 10.1111/apt.13074.
Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. Am J Gastroenterol. 2018 Oct;113(10):1540-1549. doi: 10.1038/s41395-018-0262-x.
Flacco ME, Manzoli L, De Giorgio R, Gasbarrini A, Cicchetti A, Bravi F, et al. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2986-3000. doi: 10.26355/eurrev_201904_17580.
Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm. 2013 Nov-Dec;19(9):755-64. doi: 10.18553/jmcp.2013.19.9.755.
Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014 Nov;40(9):1023-34. doi: 10.1111/apt.12938.
Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol. 2014 Jul 21;20(27):8807-20. doi: 10.3748/wjg.v20.i27.8807.
Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr;105(4):833-41. doi: 10.1038/ajg.2010.116.
Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001 Oct;121(4):799-804. doi: 10.1053/gast.2001.27995.
Kalantar JS, Locke GR 3rd, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec;52(12):1703-7. doi: 10.1136/gut.52.12.1703.
Bengtson MB, Rønning T, Vatn MH, Harris JR. Irritable bowel syndrome in twins: genes and environment. Gut. 2006 Dec;55(12):1754-9. doi: 10.1136/gut.2006.097287.
Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut. 2003 Jan;52(1):91-3. doi: 10.1136/gut.52.1.91. PMID: 12477767; PMCID: PMC1773523.
Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol. 2010 Jan;30(1):74-9. doi: 10.1007/s10875-009-9342-4.
Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am. 2005 Jun;34(2):305-17. doi: 10.1016/j.gtc.2005.02.009.
Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct;303(7):G775-85. doi: 10.1152/ajpgi.00155.2012.
Mertz H. Review article: visceral hypersensitivity. Aliment Pharmacol Ther. 2003 Mar 1;17(5):623-33. doi: 10.1046/j.1365-2036.2003.01447.x.
Gao J, Xiong T, Grabauskas G, Owyang C. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2. Gastroenterology. 2022 Jun;162(7):1962-1974.e6. doi: 10.1053/j.gastro.2022.02.016.
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004 Jun;126(7):1657-64. doi: 10.1053/j.gastro.2004.03.013.
Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, et al. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011 Oct;17(4):349-59. doi: 10.5056/jnm.2011.17.4.349.
Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. ; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013 Jan;62(1):159-76. doi: 10.1136/gutjnl-2012-302167.
Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther. 2014 May;39(10):1033-42. doi: 10.1111/apt.12728.
Mujagic Z, Kasapi M, Jonkers DM, Garcia-Perez I, Vork L, Weerts ZZRM, et al. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes. 2022 Jan-Dec;14(1):2063016. doi: 10.1080/19490976.2022.2063016.
Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012 Jul;18(3):258-68. doi: 10.5056/jnm.2012.18.3.258.
Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995 Jan 15;122(2):107-12. doi: 10.7326/0003-4819-122-2-199501150-00005.
Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol. 2021 Jul 1;116(7):1485-1494. doi: 10.14309/ajg.0000000000001247.
Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002 Sep;51(3):410-3. doi: 10.1136/gut.51.3.410.
Blanchard EB, Lackner JM, Jaccard J, Rowell D, Carosella AM, Powell C, Sanders K, Krasner S, Kuhn E. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res. 2008 Feb;64(2):119-28. doi: 10.1016/j.jpsychores.2007.10.010.
Larauche M, Mulak A, Taché Y. Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. J Neurogastroenterol Motil. 2011 Jul;17(3):213-34. doi: 10.5056/jnm.2011.17.3.213.
Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036.
Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018 Dec;93(12):1858-1872. doi: 10.1016/j.mayocp.2018.04.032.
Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):13-23. doi: 10.1038/nrgastro.2012.207.
https://www.who.int/news-room/fact-sheets/detail/physical-activity Access date: 27.05.2024.
Ho FF, Sun H, Zheng H, Wong DCN, Gao YY, Mao C, et al. Association of healthy lifestyle behaviours with incident irritable bowel syndrome: a large population-based prospective cohort study. Gut. 2024 Feb 20:gutjnl-2023-331254. doi: 10.1136/gutjnl-2023-331254.
Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011 May;106(5):915-22. doi: 10.1038/ajg.2010.480.
Johannesson E, Ringström G, Abrahamsson H, Sadik R. Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects. World J Gastroenterol. 2015 Jan 14;21(2):600-8. doi: 10.3748/wjg.v21.i2.600.
Johannesson E, Jakobsson Ung E, Sadik R, Ringström G. Experiences of the effects of physical activity in persons with irritable bowel syndrome (IBS): a qualitative content analysis. Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1194-1200. doi: 10.1080/00365521.2018.1519596.
Dainese R, Serra J, Azpiroz F, Malagelada JR. Effects of physical activity on intestinal gas transit and evacuation in healthy subjects. Am J Med. 2004 Apr 15;116(8):536-9. doi: 10.1016/j.amjmed.2003.12.018.
Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, et al. Neurobiology of exercise. Obesity (Silver Spring). 2006 Mar;14(3):345-56. doi: 10.1038/oby.2006.46.
Koseki T, Muratsubaki T, Tsushima H, Morinaga Y, Oohashi T, Imafuku M, et al. Impact of mindfulness tendency and physical activity on brain-gut interactions. J Gastroenterol. 2023 Feb;58(2):158-170. doi: 10.1007/s00535-022-01938-9.
Johannesson E, Jakobsson Ung E, Ringström G, Sadik R. The experiences of physical activity in irritable bowel syndrome-A qualitative study. J Clin Nurs. 2019 Sep;28(17-18):3189-3199. doi: 10.1111/jocn.14880.
Shahabi L, Naliboff BD, Shapiro D. Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study. Psychol Health Med. 2016;21(2):176-88. doi: 10.1080/13548506.2015.1051557.
Bianco A, Russo F, Franco I, Riezzo G, Donghia R, Curci R, et al. Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise. J Clin Med. 2023 Oct 26;12(21):6786. doi: 10.3390/jcm12216786.
D'Silva A, MacQueen G, Nasser Y, Taylor LM, Vallance JK, Raman M. Yoga as a Therapy for Irritable Bowel Syndrome. Dig Dis Sci. 2020 Sep;65(9):2503-2514. doi: 10.1007/s10620-019-05989-6.
Kavuri V, Selvan P, Malamud A, Raghuram N, Selvan SR. Remedial yoga module remarkably improves symptoms in irritable bowel syndrome patients: A 12-week randomized controlled trial. Eur J Integr Med. 2015 Dec 7(6):595-608. doi: 10.1016/j.eujim.2015.11.001.
Taneja I, Deepak KK, Poojary G, Acharya IN, Pandey RM, Sharma MP. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback. 2004 Mar;29(1):19-33. doi: 10.1023/b:apbi.0000017861.60439.95.
Evans S, Lung KC, Seidman LC, Sternlieb B, Zeltzer LK, Tsao JC. Iyengar yoga for adolescents and young adults with irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):244-53. doi: 10.1097/MPG.0000000000000366.
Kuttner L, Chambers CT, Hardial J, Israel DM, Jacobson K, Evans K. A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag. 2006 Winter;11(4):217-23. doi: 10.1155/2006/731628.
D'Silva A, Marshall DA, Vallance JK, Nasser Y, Rajagopalan V, Szostakiwskyj JH, et al. Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial. Am J Gastroenterol. 2023 Feb 1;118(2):329-337. doi: 10.14309/ajg.0000000000002052.
Weaver-Toedtman KR, Walch M, Kiracofe L, Bedingfield A, Cook L, Resnick B, et al. Feasibility and Acceptability of an Online Yoga Study Among Individuals with Irritable Bowel Syndrome (IBS). Int J Yoga Therap. 2023 Oct 1;33(2023):Article 8. doi: 10.17761/2023-D-22-00015.
Groenendijk DW, Witteman BJ, Mulder BC. The Experiences of Female IBS Patients Concerning Physical Activity as Treatment Modality: A Qualitative Study. Qual Health Res. 2022 Sep;32(11):1690-1700. doi: 10.1177/10497323221110109.
Nunan D, Cai T, Gardener AD, Ordóñez-Mena JM, Roberts NW, Thomas ET, Mahtani KR. Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ewelina Machała-Ćwikła, Urszula Łapińska, Piotr Zdziebło , Piotr Ćwikła, Kamila Machała, Kacper Szeląg, Dominika Machala, Antoni Kujawski, Andrzej Paweł Zuzak, Katarzyna Zdziebło
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 180
Number of citations: 0
